SGK1 plays a pivotal role in vascular inflammation and atherogenesis by regulating monocyte/macrophage migration and MMP-9 transcription via NF-κB.
SGK1 may be a viable therapeutic target; leaves open translation from this mouse model to patients.
No takes yet. Share an insight, caveat, or question.
Borst et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: